#35 PHARM Part-13 Migraine Assessment and Treatment

$59.00

This is a product page for purchasing this course. To go to the course page click here

2.0 CE Total | 1.5 Pharm

Migraine is neither an “extreme headache” nor a psychosomatic condition, as many patients and some healthcare providers continue to believe. One of the most pervasive misconceptions is that migraine is a vascular disease. Current and emerging evidence disproves this notion and has established that migraine has a distinctive physiology based on a neurological process. Due to poor understanding of the condition, migraine is often misdiagnosed – or not diagnosed at all. It is frequently mistaken for tension-type or sinus headache, even though headache specialists consider the latter to be relatively rare.

SKU: NAEMCDAMonthlyWebinar#35 Category:

Description

This is a product page for purchasing this course. To go to the course page click here

Abstract

Migraine is neither an “extreme headache” nor a psychosomatic condition, as many patients and some healthcare providers continue to believe. One of the most pervasive misconceptions is that migraine is a vascular disease. Current and emerging evidence disproves this notion and has established that migraine has a distinctive physiology based on a neurological process. Due to poor understanding of the condition, migraine is often misdiagnosed – or not diagnosed at all. It is frequently mistaken for tension-type or sinus headache, even though headache specialists consider the latter to be relatively rare.

CME Outline:

  • Background–Prevalence and Epidemiology
  • Diagnosis
  • Common pharmaceutical therapies
  • Naturopathic Options
  • Neurosteroids
  • Emerging therapies
  • Resources

There are no reviews yet.

Be the first to review “#35 PHARM Part-13 Migraine Assessment and Treatment”